DefiniGEN generate high-quality, phenotypically relevant disease modeled hepatocytes that can be utilized to screen compounds.

Our highly predictive hepatocyte-like cells successfully recapitulate key aspects of disease pathophysiology across a wide-range of conditions that affect different aspects of liver function. We have a large panel of iPSC lines allowing us to offer all our disease models and cell-based bioassays in donors ranging in gender, age and ethnicity.

Researchers use our donor panels to further screen their lead candidates and potentially inform the stratification of a successful clinical trial.